Royal Bank Of Canada Ampio Pharmaceuticals, Inc. Transaction History

Royal Bank Of Canada

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.16 - $0.47 $2,318 - $6,809	-14,488 Reduced 95.97%	608 $0
Q1 2022 May 16, 2022	SELL	$0.42 - $0.62 $14,344 - $21,174	-34,153 Reduced 69.35%	15,096 $7,000
Q4 2021 Feb 14, 2022	BUY	$0.56 - $1.71 $12,927 - $39,473	23,084 Added 88.22%	49,249 $28,000
Q3 2021 Nov 15, 2021	BUY	$1.21 - $1.8 $12,074 - $17,962	9,979 Added 61.65%	26,165 $43,000
Q2 2021 Aug 16, 2021	BUY	$1.56 - $1.98 $25,250 - $32,048	16,186 New	16,186 $27,000

96.6K

Ticker AMPE
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 226,287,008
Market Cap $2.26M
Description
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee; AP-017, an...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.